Mcdonald Capital Investors Inc Regeneron Pharmaceuticals, Inc. Transaction History

Mcdonald Capital Investors Inc

$1.5 Billion
Q3 2024

A detailed history of Mcdonald Capital Investors Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mcdonald Capital Investors Inc holds 136,453 shares of REGN stock, worth $95.8 Million. This represents 9.55% of its overall portfolio holdings.

Number of Shares

136,453

Previous 139,199 1.97%

Holding current value

$95.8 Million

Previous $146 Million 1.95%

% of portfolio

9.55%

Previous 9.77%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$1024.09 - $1201.76 $2.81 Million - $3.3 Million	-2,746 Reduced 1.97%	136,453 $143 Million
Q2 2024 Aug 01, 2024	SELL	$883.2 - $1071.19 $1.6 Million - $1.94 Million	-1,814 Reduced 1.29%	139,199 $146 Million
Q1 2024 May 03, 2024	SELL	$902.69 - $993.35 $2.27 Million - $2.5 Million	-2,516 Reduced 1.75%	141,013 $136 Million
Q4 2023 Jan 30, 2024	SELL	$775.18 - $881.7 $2.01 Million - $2.28 Million	-2,590 Reduced 1.77%	143,529 $126 Million
Q3 2023 Oct 27, 2023	SELL	$692.45 - $844.37 $2.13 Million - $2.6 Million	-3,080 Reduced 2.06%	146,119 $120 Million
Q2 2023 Jul 11, 2023	SELL	$700.03 - $830.35 $2.29 Million - $2.71 Million	-3,265 Reduced 2.14%	149,199 $107 Million
Q1 2023 Jul 11, 2023	SELL	$680.49 - $826.97 $2.8 Million - $3.41 Million	-4,122 Reduced 2.63%	152,464 $125 Million
Q4 2022 Feb 07, 2023	SELL	$705.89 - $766.39 $3.1 Million - $3.36 Million	-4,385 Reduced 2.72%	156,586 $113 Million
Q3 2022 Nov 04, 2022	SELL	$573.97 - $724.32 $1.79 Million - $2.25 Million	-3,111 Reduced 1.9%	160,971 $111 Million
Q2 2022 Aug 01, 2022	SELL	$548.35 - $738.84 $839,523 - $1.13 Million	-1,531 Reduced 0.92%	164,082 $97 Million
Q1 2022 May 02, 2022	SELL	$595.12 - $698.43 $321,364 - $377,152	-540 Reduced 0.33%	165,613 $116 Million
Q4 2021 Feb 03, 2022	SELL	$543.48 - $670.97 $910,329 - $1.12 Million	-1,675 Reduced 1.0%	166,153 $105 Million
Q3 2021 Nov 03, 2021	SELL	$574.03 - $680.96 $3.79 Million - $4.5 Million	-6,610 Reduced 3.79%	167,828 $102 Million
Q2 2021 Aug 03, 2021	SELL	$472.8 - $558.54 $1.59 Million - $1.88 Million	-3,368 Reduced 1.89%	174,438 $97.4 Million
Q1 2021 Apr 23, 2021	SELL	$446.73 - $548.2 $163,056 - $200,093	-365 Reduced 0.2%	177,806 $84.1 Million
Q4 2020 Feb 05, 2021	SELL	$478.3 - $607.98 $845,634 - $1.07 Million	-1,768 Reduced 0.98%	178,171 $86.1 Million
Q3 2020 Nov 09, 2020	SELL	$544.75 - $658.21 $740,315 - $894,507	-1,359 Reduced 0.75%	179,939 $101 Million
Q2 2020 Jul 30, 2020	SELL	$493.32 - $643.92 $5.07 Million - $6.61 Million	-10,270 Reduced 5.36%	181,298 $113 Million
Q1 2020 Apr 30, 2020	SELL	$336.18 - $494.43 $1.44 Million - $2.12 Million	-4,295 Reduced 2.19%	191,568 $93.5 Million
Q4 2019 Feb 07, 2020	SELL	$274.13 - $376.51 $3.79 Million - $5.2 Million	-13,817 Reduced 6.59%	195,863 $73.5 Million
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $4.56 Million - $5.31 Million	16,680 Added 8.64%	209,680 $58.2 Million
Q2 2019 Aug 06, 2019	BUY	$299.6 - $414.82 $17.4 Million - $24.1 Million	58,015 Added 42.98%	193,000 $60.4 Million
Q1 2019 May 01, 2019	SELL	$372.08 - $439.57 $2.02 Million - $2.39 Million	-5,435 Reduced 3.87%	134,985 $55.4 Million
Q4 2018 Feb 01, 2019	BUY	$335.82 - $403.04 $12.1 Million - $14.5 Million	35,885 Added 34.33%	140,420 $52.4 Million
Q3 2018 Oct 31, 2018	BUY	$351.14 - $408.51 $33 Million - $38.4 Million	94,035 Added 895.57%	104,535 $42.2 Million
Q2 2018 Jul 30, 2018	BUY	$284.6 - $344.99 $2.99 Million - $3.62 Million	10,500 New	10,500 $3.62 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdonald Capital Investors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcdonald Capital Investors Inc with notifications on news.

Account

Mcdonald Capital Investors Inc Regeneron Pharmaceuticals, Inc. Transaction History